BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Lilly Announces 15% Dividend Increase, First-Quarter 2023 Dividend

The dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023. Lilly unites caring with ...

December 13, 2022 | News

Medtronic announces cash dividend for third quarter of fiscal year 2023

This quarterly declaration is consistent with the dividend announcement made by the company in May 2022. Medtronic is a constituent of the S&P 500...

December 09, 2022 | News

Sartorius agrees with BICO on strategic cooperation as well as a 10 percent capital investment

BICO Group is a pioneer and leading provider of instruments and consumables for bioprinting, bioscience and bioautomation applications in the life scienc...

December 08, 2022 | News

BRIM Biotechnology, Inc. raises $20 million in Series E funding round

Since the company’s inception in 2013, BRIM has successfully developed several platform technologies, including the regenerative peptide technology (...

December 05, 2022 | News

Agilent Reports Fourth-Quarter and Fiscal Year 2022 Financial Results

Fourth-quarter fiscal year 2022 Revenue of $1.85 billion represents 11% reported growth year-over-year; and up 17% on a core(1) basis. GAAP net in...

November 24, 2022 | News

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

Fujifilm’s fifth media manufacturing site to be operated by FUJIFILM Irvine Scientific Triples the company’s current capacity for liquid cel...

November 23, 2022 | News

GE Announces Closing of Offering of $8.25 Billion Senior Notes issued by GE HealthCare

The Notes were offered as part of the financing for the proposed spin-off of GE HealthCare from GE (the “Spin-Off”), which is expected to be co...

November 23, 2022 | News

Cyclica receives CAD$2.4M grant for a multi-targeted drug discovery program to advance non-hormonal contraceptive medicines

Cyclica Inc., a neo-biotech that is unlocking the protein universe to discover the medicines of tomorrow, is developing new, non-hormonal contraceptives fo...

November 15, 2022 | News

Merck Confirms Guidance for 2022 and Delivers Strong Organic Growth in Q3

Results of the third quarter of 2022 Group net sales rise by 16.8% to € 5.8 billion Strong organic sales growth of 7.1%, driven by the &...

November 14, 2022 | News

Orgenesis Secures up to $50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services

Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potent...

November 08, 2022 | News

Lilly Announces 15% Dividend Increase, First-Quarter 2023 Dividend

Medtronic announces cash dividend for third quarter of fiscal year 2023

Sartorius agrees with BICO on strategic cooperation as well as a 10 percent capital investment

BRIM Biotechnology, Inc. raises $20 million in Series E funding round

Agilent Reports Fourth-Quarter and Fiscal Year 2022 Financial Results

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

GE Announces Closing of Offering of $8.25 Billion Senior Notes issued by GE HealthCare

Cyclica receives CAD$2.4M grant for a multi-targeted drug discovery program to advance non-hormonal contraceptive medicines

Merck Confirms Guidance for 2022 and Delivers Strong Organic Growth in Q3

Orgenesis Secures up to $50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services

Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company

LAXAI Receives Investment from SIGNET Healthcare Partners

Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement

MedAlliance to be Acquired by Cordis

Stay Connected